about
Biochemical functions of coenzyme Q10Mitochondrial dysfunction on sinoatrial node and pulmonary vein electrophysiological activitiesCoenzyme Q supplementation in pulmonary arterial hypertension.Effect of coenzyme Q₁₀ supplementation on heart failure: a meta-analysisCoenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics.Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'.Beneficial Effects of Coenzyme Q10 Supplementation on Lipid Profile and Intereukin-6 and Intercellular Adhesion Molecule-1 Reduction, Preliminary Results of a Double-blind Trial in Acute Myocardial InfarctionCoenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials.Studies on free radicals, antioxidants, and co-factorsInhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease.Nutrition and nutraceutical supplements in the treatment of hypertension.Micronutrients in chronic heart failure.Evidence of clinically relevant efficacy for dietary supplements and nutraceuticals.Nutraceuticals and Blood Pressure Control: Results from Clinical Trials and Meta-Analyses.Nutraceuticals for blood pressure control.Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach.Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses.Coenzyme Q10 and Utility in Heart Failure: Just Another Supplement?Attenuation of UV-induced apoptosis by coenzyme Q10 in human cells harboring large-scale deletion of mitochondrial DNA.Oxidative stress in dog with heart failure: the role of dietary Fatty acids and antioxidants.Genetic evidence for the requirement of the endocytic pathway in the uptake of coenzyme Q6 in Saccharomyces cerevisiaeUptake of exogenous coenzyme Q and transport to mitochondria is required for bc1 complex stability in yeast coq mutants.Elevated hydroperoxide levels and antioxidant patterns in Papillon-Lefèvre syndrome.Formulation and evaluation of ubidecarenone transdermal delivery systems.Supplementation with an antioxidant cocktail containing coenzyme Q prevents plasma oxidative damage induced by soccer.Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind study.
P2860
Q28611180-515B29DC-CDC9-4375-B930-24034C42F71FQ33723969-492D803E-498A-4FFA-8D9F-3E7832F99716Q34085977-1E77949A-2096-493B-A318-B581898AF359Q34316289-D49615C9-B9B4-4C1E-A87C-61618E9B2A53Q34503981-2D9806B2-D0FD-432F-9492-56D7E3076A7AQ35837905-2FBC4115-1C4D-4D30-B91E-2A8343CDC805Q35973462-50574EF2-461F-4059-85ED-FAF5946C87BAQ36731119-B3992E02-3CEB-41ED-957D-AA34F3F87C90Q37017403-076B6457-7F52-4951-9A60-042447DDBB89Q37616206-493C6B56-F881-4CAA-BE5A-2286015AF473Q37733176-FF724AE8-47E0-4ECB-AF6C-9B898A5F4ED2Q37763200-49EC77C9-27DB-49A8-A615-C920ED16A655Q38052455-4ADECEC1-2FE3-42EB-9EB8-72C8B629C842Q38083611-6D800BB4-20DB-48D9-B4E5-0F5BE0AA3A99Q38383349-12D022E4-90DB-4FA1-AE0F-BFA3D7784324Q38585203-BC0C1341-0921-485B-AB62-E69359F3E79AQ38679373-846C1FAA-6918-47D4-B8B3-C6B023191765Q38725236-F852B6B0-6854-4267-A882-2AF7B72E0F9FQ38873521-440B353D-D69A-4299-8F19-ABBE26D778EDQ40407433-3C0B0FA1-BA62-4F09-A941-3FC78D43EDE6Q41830721-D359C08E-772A-4A88-97BE-256F007C4317Q41916653-75757BFB-8F91-48BE-8E9C-C6218068615AQ43852903-A5772E6A-F3D2-4E9B-9E4A-FA2B2E05009DQ43866449-E05BFEF1-796C-4E34-B004-F70E29F1148AQ46051657-6666068E-9370-4855-A18F-42EAEE74F6DAQ46456471-7A0163EC-C720-4C66-9A22-F1DABA328858Q48699190-063E8C0F-9173-49B7-AD6D-5E90530EE777
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Overview of the use of CoQ10 in cardiovascular disease.
@ast
Overview of the use of CoQ10 in cardiovascular disease.
@en
type
label
Overview of the use of CoQ10 in cardiovascular disease.
@ast
Overview of the use of CoQ10 in cardiovascular disease.
@en
prefLabel
Overview of the use of CoQ10 in cardiovascular disease.
@ast
Overview of the use of CoQ10 in cardiovascular disease.
@en
P356
P1433
P1476
Overview of the use of CoQ10 in cardiovascular disease.
@en
P2093
Langsjoen AM
Langsjoen PH
P2860
P304
P356
10.1002/BIOF.5520090224
P577
1999-01-01T00:00:00Z